Stanford University, Dept. of Dermatology

Redwood City, California 94063

1 studies enrolling now · 1 studies all time

What they study most

Pemphigus Vulgaris

Studies at this site

• A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV) — Recruiting now